Stock Research for LXRP

LXRP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRP Stock Chart & Research Data

The LXRP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRP Due diligence Resources & Stock Charts

The LXRP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRP Detailed Price Forecast - CNN Money CNN View LXRP Detailed Summary - Google Finance
Yahoo View LXRP Detailed Summary - Yahoo! Finance Zacks View LXRP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRP Trends & Analysis - Trade-Ideas Barrons View LXRP Major Holders - Barrons
NASDAQ View LXRP Call Transcripts - NASDAQ Seeking View LXRP Breaking News & Analysis - Seeking Alpha
Spotlight View LXRP Annual Report - CompanySpotlight.com OTC Report View LXRP OTC Short Report - OTCShortReport.com
TradeKing View LXRP Fundamentals - TradeKing Charts View LXRP SEC Filings - Bar Chart
WSJ View Historical Prices for LXRP - The WSJ Morningstar View Performance/Total Return for LXRP - Morningstar
MarketWatch View the Analyst Estimates for LXRP - MarketWatch CNBC View the Earnings History for LXRP - CNBC
StockMarketWatch View the LXRP Earnings - StockMarketWatch MacroAxis View LXRP Buy or Sell Recommendations - MacroAxis
Bullish View the LXRP Bullish Patterns - American Bulls Short Pains View LXRP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRP Stock Mentions - StockTwits PennyStocks View LXRP Stock Mentions - PennyStockTweets
Twitter View LXRP Stock Mentions - Twitter Invest Hub View LXRP Investment Forum News - Investor Hub
Yahoo View LXRP Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRP - SECform4.com Insider Cow View Insider Transactions for LXRP - Insider Cow
CNBC View LXRP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRP - OTC Markets
Yahoo View Insider Transactions for LXRP - Yahoo! Finance NASDAQ View Institutional Holdings for LXRP - NASDAQ


Stock Charts

FinViz View LXRP Stock Insight & Charts - FinViz.com StockCharts View LXRP Investment Charts - StockCharts.com
BarChart View LXRP Stock Overview & Charts - BarChart Trading View View LXRP User Generated Charts - Trading View




Latest Financial News for LXRP


Lexaria Bioscience Expands Staff, Issues Options
Posted on Friday December 07, 2018

KELOWNA, BC / ACCESSWIRE / December 7, 2018 / Lexaria Bioscience Corp. (LXRP) (CNSX:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the following updates. In the New Year, Lexaria expects to begin hiring additional new laboratory personnel as its R&D operations intensify. As a result of the latest positions created, Lexaria is issuing 240,000 stock options with an exercise price of US$1.06, that will vest as to 80,000 per year until April 15, 2021.


CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Holds Enviable Position in Rise of Cannabis Edibles
Posted on Friday November 30, 2018

New York, New York--(Newsfile Corp. - November 30, 2018) -  CannabisNewsAudio announces the Audio Press Release (APR) titled "Booming Cannabis Consumables Space Continues to See Product Innovations," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).To hear the CannabisNewsAudio version, visit: http://cnw.fm/IxM3OTo read the full editorial, visit: http://cnw.fm/qzN9LLexaria's proprietary technology is patent protected for CBD and other nonpsychoactive cannabinoids and has patents pending for THC, other psychoactive cannabinoids, NSAIDs (non-steroidal anti-inflammatory drugs), nicotine and other ...


CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Capitalizing on Technology in CBD-Infused Products
Posted on Friday November 30, 2018

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- via CannabisNewsWire – CannabisNewsAudio announces the Audio Press Release (APR) titled “Booming Cannabis Consumables Space Continues to see Product Innovations,” featuring Lexaria Bioscience Corp. (CSE:LXX) (LXRP). Capitalizing on its bioavailability-enhancing technology and established presence as a CBD-infused product developer, Lexaria has now moved to tackle the U.S. soft drinks market, which is expected to be worth $388 billion-plus by 2025, introducing a discreet, single-serving foil packet cannabinoid drink powder named ChrgD+. Lexaria is confident that a small two-gram foil packet that can be discreetly carried in a shirt pocket or purse for incorporation into a beverage will be a big hit.


CannabisNewsWire Announces Growing Cannabis Acceptance Setting Stage For Consumable Cannabis Boom
Posted on Thursday November 29, 2018

NEW YORK, Nov. 29, 2018 -- via CannabisNewsWire -- CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.